Form 8-K - Current report:
SEC Accession No. 0000950170-22-004311
Filing Date
2022-03-22
Accepted
2022-03-22 16:36:06
Documents
13
Period of Report
2022-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20220318.htm   iXBRL 8-K 59130
2 EX-10.1 dsgn-ex10_1.htm EX-10.1 104232
  Complete submission text file 0000950170-22-004311.txt   302521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20220318_lab.xml EX-101.LAB 14564
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20220318_pre.xml EX-101.PRE 10677
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20220318.xsd EX-101.SCH 2487
7 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20220318_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 22760080
SIC: 2834 Pharmaceutical Preparations